APA

Adachi Y., Yanagimura N., Suzuki C., Ootani S., Tanimoto A., Nishiyama A., Yamashita K., Ohtsubo K., Takeuchi S. & Yano S. (20200929). Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report. : BMC cancer.

Chicago

Adachi Yuta, Yanagimura Naohiro, Suzuki Chiaki, Ootani Sakiko, Tanimoto Azusa, Nishiyama Akihiro, Yamashita Kaname, Ohtsubo Koushiro, Takeuchi Shinji and Yano Seiji. 20200929. Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report. : BMC cancer.

Harvard

Adachi Y., Yanagimura N., Suzuki C., Ootani S., Tanimoto A., Nishiyama A., Yamashita K., Ohtsubo K., Takeuchi S. and Yano S. (20200929). Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report. : BMC cancer.

MLA

Adachi Yuta, Yanagimura Naohiro, Suzuki Chiaki, Ootani Sakiko, Tanimoto Azusa, Nishiyama Akihiro, Yamashita Kaname, Ohtsubo Koushiro, Takeuchi Shinji and Yano Seiji. Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report. : BMC cancer. 20200929.